Covid hangover: Pfizer reported revenues of £11.9bn for the first three months of 2024

Covid hangover: Pfizer reported revenues of £11.9bn for the first three months of 2024

US drugs giant Pfizer posted a drop in sales in a post-Covid vaccine slump.

It reported revenues of £11.9billion for the first three months of 2024, down a fifth year-on-year, as it tries to regain its footing after the rapid decline of its Covid business.

Sales of the vaccine fell 88 per cent to £283million.  But shares rallied on Wall Street as bosses lifted a key profit metric by 5 per cent for 2024, amid ‘confidence’ in its business and ability to slash costs.

It said it was on track to deliver at least £3.5billion in savings this year. 

The company has also put a greater focus on cancer treatments after snapping up drugmaker Seagen for £34billion last year.

Excluding Covid products, revenue for the first quarter climbed 11 per cent.

But sales of its vaccine for protection against respiratory syncytial virus (RSV) fell short.

Dr Albert Bourla, the chief executive, said that a well-executed quarter was ‘setting the tone for the year’.

Pfizer’s value soared during the pandemic after it launched a Covid vaccine but retreated as lockdowns were lifted. 

Today it has a market cap of around £116billion, less than half of its pandemic-era peak at the end of 2021.

This post first appeared on Dailymail.co.uk

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

ALEX BRUMMER: Government must play a hand to bring Arm back to Britain

When Softbank arranged the £30billion sale of Britain’s top technology firm, Cambridge-based…

Debenhams shoppers share their bargains as stores shut for the last time

DEBENHAMS shoppers have been showing off their bargains as the department store…

Fifth self-employment grant: When can I apply for and how much will SEISS boost be?

CHANCELLOR Rishi Sunak has confirmed there will be a fifth grant for…

Capita bosses in crisis talks with new advisers over turnaround plan

Capita bosses are locked in crisis talks with new advisers as they…